{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:45:16Z","timestamp":1764510316889},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T00:00:00Z","timestamp":1177459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10549-007-9572-1","type":"journal-article","created":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T18:34:55Z","timestamp":1177439695000},"page":"1-7","source":"Crossref","is-referenced-by-count":36,"title":["Controversies in preservation of ovary function and fertility in patients with breast cancer"],"prefix":"10.1007","volume":"108","author":[{"given":"Bernd","family":"Gerber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Dieterich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toralf","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,25]]},"reference":[{"key":"9572_CR1","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","volume":"24","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917\u20132931","journal-title":"J Clin Oncol"},{"key":"9572_CR2","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2002.20.24.4611","volume":"20","author":"KI Pritchard","year":"2002","unstructured":"Pritchard KI (2002) Adjuvant therapy for premenopausal women with breast cancer: is it time for another paradigm shift? J Clin Oncol 20:4611\u20134614","journal-title":"J Clin Oncol"},{"key":"9572_CR3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/cncr.21385","volume":"104","author":"MN Fornier","year":"2005","unstructured":"Fornier MN, Modi S, Panageas KS, Norton L, Hudis C (2005) Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40\u00a0years and younger after adjuvant anthracycline and taxane. Cancer 104:1575\u20131579","journal-title":"Cancer"},{"key":"9572_CR4","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1200\/JCO.2003.11.064","volume":"21","author":"H Haes De","year":"2003","unstructured":"De Haes H, Olschewski M, Kaufmann M, Schumacher M, Jonat W, Sauerbrei W (2003) Quality of life in goserelin-treated versus cyclophosphamide\u00a0+\u00a0methotrexate\u00a0+\u00a0fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the zoladex early breast cancer research association trialists group. J Clin Oncol 21:4510\u20134516","journal-title":"J Clin Oncol"},{"key":"9572_CR5","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2003.04.196","volume":"21","author":"PA Ganz","year":"2003","unstructured":"Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21:4184\u20134193","journal-title":"J Clin Oncol"},{"key":"9572_CR6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.maturitas.2005.11.002","volume":"54","author":"R Ghidoni","year":"2006","unstructured":"Ghidoni R, Boccardi M, Benussi L, Testa C, Villa A, Pievani M, Gigola L, Sabattoli F, Barbiero L, Frisoni GB, Binetti G (2006) Effects of estrogens on cognition and brain morphology: involvement of the cerebellum. Maturitas 54:222\u2013228","journal-title":"Maturitas"},{"key":"9572_CR7","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1200\/JCO.2003.04.024","volume":"21","author":"M Nystedt","year":"2003","unstructured":"Nystedt M, Berglund G, Bolund C, Fornander T, Rutqvist LE (2003) Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol 21:1836\u20131844","journal-title":"J Clin Oncol"},{"key":"9572_CR8","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.2003.01.119","volume":"21","author":"N Tchen","year":"2003","unstructured":"Tchen N, Juffs HG, Downie FP, Yi QL, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175\u20134183","journal-title":"J Clin Oncol"},{"key":"9572_CR9","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"EBCTCG","year":"2005","unstructured":"EBCTCG (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687\u20131717","journal-title":"Lancet"},{"key":"9572_CR10","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1200\/JCO.2005.01.134","volume":"23","author":"CM Duffy","year":"2005","unstructured":"Duffy CM, Allen SM, Clark MA (2005) Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23:766\u2013773","journal-title":"J Clin Oncol"},{"key":"9572_CR11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","volume":"363","author":"L Holmberg","year":"2004","unstructured":"Holmberg L, Anderson H (2004) HABITS (hormonal replacement therapy after breast cancer\u2013is it safe?), a randomised comparison: trial stopped. Lancet 363:453\u2013455","journal-title":"Lancet"},{"key":"9572_CR12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1095\/biolreprod52.2.365","volume":"52","author":"K Ataya","year":"1995","unstructured":"Ataya K, Rao LV, Lawrence E, Kimmel R (1995) Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 52:365\u2013372","journal-title":"Biol Reprod"},{"key":"9572_CR13","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2006-0020","volume":"91","author":"W Chemaitilly","year":"2006","unstructured":"Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Robison LL, Sklar CA (2006) Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 91:1723\u20131728","journal-title":"J Clin Endocrinol Metab"},{"key":"9572_CR14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/djj243","volume":"98","author":"CA Sklar","year":"2006","unstructured":"Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y, Robison LL (2006) Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 98:890\u2013896","journal-title":"J Natl Cancer Inst"},{"key":"9572_CR15","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2005.03.3969","volume":"24","author":"JA Petrek","year":"2006","unstructured":"Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, Sukumvanich P (2006) Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 24:1045\u20131051","journal-title":"J Clin Oncol"},{"key":"9572_CR16","first-page":"795","volume":"112","author":"H Muller","year":"1990","unstructured":"Muller H (1990) Effects of adjuvant chemotherapy of breast cancer on gonadal function. Zentralbl Gynakol 112:795\u2013801","journal-title":"Zentralbl Gynakol"},{"key":"9572_CR17","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609\u20131615","journal-title":"N Engl J Med"},{"key":"9572_CR18","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van\u2019t Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616\u20131622","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"9572_CR19","first-page":"S10","volume":"100","author":"J Cuzick","year":"2006","unstructured":"Cuzick J (2006) The impact of LHRH agonists on breast cancer recurrence and mortality: an overview of the randomized trials. Breast Cancer Res Treat 100(Suppl. 1):S10","journal-title":"Breast Cancer Res Treat"},{"key":"9572_CR20","unstructured":"EBCTCG (2000) Ovarian ablation for early breast cancer. Cochrane Database Syst Rev: CD000485"},{"issue":"Suppl 1","key":"9572_CR21","first-page":"S10","volume":"100","author":"M Gnant","year":"2006","unstructured":"Gnant M, Greil R, Kubista E, Menzel C, Schippinger W, Seifert B, Haider K, Jakesz R (2006) The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine-responsive breast cancer: 10-year result of ABCSG-05 (CMF vs. goserelin\u00a0+\u00a0tamoxifen). Breast Cancer Res Treat 100(Suppl 1):S10","journal-title":"Breast Cancer Res Treat"},{"key":"9572_CR22","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1200\/JCO.2002.08.169","volume":"20","author":"RR Love","year":"2002","unstructured":"Love RR, Duc NB, Allred DC, Binh NC, Dinh NV, Kha NN, Thuan TV, Mohsin SK, Roanh lD, Khang HX, Tran TL, Quy TT, Thuy NV, The PN, Cau TT, Tung ND, Huong DT, Quang lM, Hien NN, Thuong L, Shen TZ, Xin Y, Zhang Q, Havighurst TC, Yang YF, Hillner BE, DeMets DL (2002) Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer. J Clin Oncol 20:2559\u20132566","journal-title":"J Clin Oncol"},{"key":"9572_CR23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1200\/JCO.2001.19.2.343","volume":"19","author":"JG Klijn","year":"2001","unstructured":"Klijn JG, Blamey RW, Boccardo F, Tominaga T, Duchateau L, Sylvester R (2001) Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol 19:343\u2013353","journal-title":"J Clin Oncol"},{"key":"9572_CR24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0140-6736(01)72307-0","volume":"2","author":"GT Beatson","year":"1896","unstructured":"Beatson GT (1896) On the treatment of inoperable cases of carcinoma of the mamma. Suggestions for a new method of treatment with illustrative cases. Lancet 2:104\u2013107","journal-title":"Lancet"},{"key":"9572_CR25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3816\/CBC.2005.n.046","volume":"6","author":"AL Davis","year":"2005","unstructured":"Davis AL, Klitus M, Mintzer DM (2005) Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes. Clin Breast Cancer 6:421\u2013424","journal-title":"Clin Breast Cancer"},{"key":"9572_CR26","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1200\/JCO.2005.03.0783","volume":"24","author":"M Colleoni","year":"2006","unstructured":"Colleoni M, Gelber S, Goldhirsch A, Aebi S, Castiglione-Gertsch M, Price KN, Coates AS, Gelber RD (2006) Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13\u201393. J Clin Oncol 24:1332\u20131341","journal-title":"J Clin Oncol"},{"key":"9572_CR27","unstructured":"Braverman AS, Sawhney H, Tendler A, Patel N, Rao CS (2002) Pre-menopausal serum estradiol levels may persist after chemotherapy-induced amenorrhea in breast cancer. Proc Am Soc Clin Oncol 21:42a (abstr 164)"},{"issue":"Suppl 1","key":"9572_CR28","first-page":"P64","volume":"10","author":"M Baum","year":"2001","unstructured":"Baum M, Houghton J, Odling-Smee W, Rutqvist LE, Fornander T, Nordenskjold B, Nicolucci A, Mark RJ (2001) Adjuvant treatment of premenopausal breast cancer with zoladex and tamoxifen: results from randomized trials by the Cancer Research Campaign (CRC) Breast Cancer Trials Group, The Stockholm Breast Cancer Study Group, The South East Sweden Breast Cancer Group and Gruppo Interdisciplinare Valutazione Intervention Oncologica (GIVIO). Breast 10(Suppl 1):P64","journal-title":"Breast"},{"key":"9572_CR29","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/jnci\/djg119","volume":"95","author":"M Castiglione-Gertsch","year":"2003","unstructured":"Castiglione-Gertsch M, O\u2019Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bonetti M, Gelber RD (2003) Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial. J Natl Cancer Inst 95:1833\u20131846","journal-title":"J Natl Cancer Inst"},{"key":"9572_CR30","unstructured":"Davidson NE, O\u2019Neill A, Vukov A, Osborne CK, Martino S, White D, Abeloff MD (2003) Effect of chemohormonal therapy in premenopausal node positive , receptor positive breast cancer: an Eastern Cooperative Oncology Group Phase III Intergroup trial (E5188, Int-0101). J Clin Oncol (Proc Am Soc Clin Oncol) 21:15 (abstr)"},{"key":"9572_CR31","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1200\/JCO.2006.07.2793","volume":"24","author":"JM Walshe","year":"2006","unstructured":"Walshe JM, Denduluri N, Swain SM (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24:5769\u20135779","journal-title":"J Clin Oncol"},{"key":"9572_CR32","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/annonc\/mdi241","volume":"16","author":"M Vanhuyse","year":"2005","unstructured":"Vanhuyse M, Fournier C, Bonneterre J (2005) Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients. Ann Oncol 16:1283\u20131288","journal-title":"Ann Oncol"},{"key":"9572_CR33","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1200\/JCO.2002.05.042","volume":"20","author":"W Jonat","year":"2002","unstructured":"Jonat W, Kaufmann M, Sauerbrei W, Blamey R, Cuzick J, Namer M, Fogelman I, de Haes JC, de Matteis A, Stewart A, Eiermann W, Szakolczai I, Palmer M, Schumacher M, Geberth M, Lisboa B (2002) Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol 20:4628\u20134635","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"9572_CR34","first-page":"30","volume":"82","author":"F Borde","year":"2003","unstructured":"Borde F, Chapelle-Marcilac IFP, Hery M, Bonneterre J, Kerbrat P (2003) Role of chemo-induced amenorrhea in premenopausale, node-positive, operable breast cancer patients: 9-year follow-up results of French Adjuvant Study Group (FASG) data base. Breast Cancer Res Treat 82(Suppl 1):30","journal-title":"Breast Cancer Res Treat"},{"key":"9572_CR35","unstructured":"http:\/\/www.bqs-qualitaetsreport.de\/. BQS. (2007)"},{"key":"9572_CR36","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1200\/JCO.2006.07.4310","volume":"24","author":"L Mastro Del","year":"2006","unstructured":"Del Mastro L, Venturini M (2006) Fertility preservation strategies for breast cancer patients. J Clin Oncol 24:4220\u20134221","journal-title":"J Clin Oncol"},{"key":"9572_CR37","first-page":"166","volume":"334","author":"A Ives","year":"2006","unstructured":"Ives A, Saunders C, Bulsara M, Semmens J (2006) Pregnancy after breast cancer: population based study. BMJ 334:166\u2013167","journal-title":"BMJ"},{"key":"9572_CR38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncr.11929","volume":"100","author":"LJ Blakely","year":"2004","unstructured":"Blakely LJ, Buzdar AU, Lozada JA, Shullaih SA, Hoy E, Smith TL, Hortobagyi GN (2004) Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 100:465\u2013469","journal-title":"Cancer"},{"key":"9572_CR39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cncr.11634","volume":"98","author":"BA Mueller","year":"2003","unstructured":"Mueller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR (2003) Childbearing and survival after breast carcinoma in young women. Cancer 98:1131\u20131140","journal-title":"Cancer"},{"key":"9572_CR40","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2424::AID-CNCR17>3.0.CO;2-4","volume":"85","author":"P Velentgas","year":"1999","unstructured":"Velentgas P, Daling JR, Malone KE, Weiss NS, Williams MA, Self SG, Mueller BA (1999) Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 85:2424\u20132432","journal-title":"Cancer"},{"key":"9572_CR41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdi326","volume":"16","author":"A Goldhirsch","year":"2005","unstructured":"Goldhirsch A, Glick JH, Gelber RD, Coates A, Senn HJ (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569\u20131583","journal-title":"Ann Oncol"},{"key":"9572_CR42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0303-7207(01)00712-2","volume":"187","author":"Z Blumenfeld","year":"2002","unstructured":"Blumenfeld Z (2002) Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers. Mol Cell Endocrinol 187:93\u2013105","journal-title":"Mol Cell Endocrinol"},{"key":"9572_CR43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/09513590400027414","volume":"20","author":"HR Franke","year":"2005","unstructured":"Franke HR, Smit WM, Vermes I (2005) Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin\u2019s disease undergoing chemotherapy. Gynecol Endocrinol 20:274\u2013278","journal-title":"Gynecol Endocrinol"},{"key":"9572_CR44","first-page":"13","volume":"22","author":"K Fox","year":"2003","unstructured":"Fox K, Scialla J, Moore H (2003) Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant chemotherapy for early-stage breast cancer. Proc Am Soc Clin Oncol 22:13","journal-title":"Proc Am Soc Clin Oncol"},{"key":"9572_CR45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cncr.21646","volume":"106","author":"F Recchia","year":"2006","unstructured":"Recchia F, Saggio G, Amiconi G, Di Blasio A, Cesta A, Candeloro G, Rea S (2006) Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 106:514\u2013523","journal-title":"Cancer"},{"key":"9572_CR46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/annonc\/mdj029","volume":"17","author":"L Mastro Del","year":"2006","unstructured":"Del Mastro L, Catzeddu T, Boni L, Bell C, Sertoli MR, Bighin C, Clavarezza M, Testa D, Venturini M (2006) Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 17:74\u201378","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"9572_CR47","first-page":"S229","volume":"88","author":"A Urruticoechea","year":"2004","unstructured":"Urruticoechea A, Walsh G, Rigg A, Dowsett M, Smith IE (2004) Ovarian function protection with goserelin during adjuvant chemotherapy in pre-menopausal women with early breast cancer. Breast Cancer Res Treat 88(Suppl 1):S229","journal-title":"Breast Cancer Res Treat"},{"key":"9572_CR48","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","volume":"23","author":"K Oktay","year":"2005","unstructured":"Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347\u20134353","journal-title":"J Clin Oncol"},{"key":"9572_CR49","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1210\/jc.2006-0962","volume":"91","author":"K Oktay","year":"2006","unstructured":"Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885\u20133890","journal-title":"J Clin Endocrinol Metab"},{"key":"9572_CR50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1634\/theoncologist.11-5-422","volume":"11","author":"M Sonmezer","year":"2006","unstructured":"Sonmezer M, Oktay K (2006) Fertility preservation in young women undergoing breast cancer therapy. Oncologist 11:422\u2013434","journal-title":"Oncologist"},{"key":"9572_CR51","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(04)17222-X","volume":"364","author":"J Donnez","year":"2004","unstructured":"Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364:1405\u20131410","journal-title":"Lancet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9572-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-007-9572-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9572-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:28:49Z","timestamp":1559233729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-007-9572-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,25]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9572"],"URL":"https:\/\/doi.org\/10.1007\/s10549-007-9572-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,25]]}}}